BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Endo-Umeda K, Makishima M. Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells. Int J Mol Sci 2019;20:E5045. [PMID: 31614590 DOI: 10.3390/ijms20205045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Zhang C, Luo J, Xu H, Liu J, Loor JJ, Shi H. The LXRB-SREBP1 network regulates lipogenic homeostasis by controlling the synthesis of polyunsaturated fatty acids in goat mammary epithelial cells. J Anim Sci Biotechnol 2022;13:120. [PMID: 36336695 DOI: 10.1186/s40104-022-00774-4] [Reference Citation Analysis]
2 Hoogerland JA, Staels B, Dombrowicz D. Immune–metabolic interactions in homeostasis and the progression to NASH. Trends in Endocrinology & Metabolism 2022;33:690-709. [DOI: 10.1016/j.tem.2022.07.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Siemienowicz KJ, Filis P, Thomas J, Fowler PA, Duncan WC, Rae MT. Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”. Biomedicines 2022;10:1291. [DOI: 10.3390/biomedicines10061291] [Reference Citation Analysis]
4 Cheng H, Wang M, Su J, Li Y, Long J, Chu J, Wan X, Cao Y, Li Q. Lipid Metabolism and Cancer. Life 2022;12:784. [DOI: 10.3390/life12060784] [Reference Citation Analysis]
5 Bideyan L, Fan W, Kaczor-Urbanowicz KE, Priest C, Casero D, Tontonoz P. Integrative analysis reveals multiple modes of LXR transcriptional regulation in liver. Proc Natl Acad Sci U S A 2022;119:e2122683119. [PMID: 35145035 DOI: 10.1073/pnas.2122683119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xiang M, Liu T, Tian C, Ma K, Gou J, Huang R, Li S, Li Q, Xu C, Li L, Lee CH, Zhang Y. For the Topic - The New Therapeutic Approaches, Biomarkers and Molecular Mechanisms of Organ Fibrosis and COVID19 Rehabilitation Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway. Pharmacol Res 2022;:106092. [PMID: 35066108 DOI: 10.1016/j.phrs.2022.106092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Heintze T, Wilhelm D, Schmidlin T, Hofmann U, Zanger UM, Schwab M, Klein K. Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis. Front Pharmacol 2021;12:769703. [PMID: 34867397 DOI: 10.3389/fphar.2021.769703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li B, Lian M, Li Y, Qian Q, Zhang J, Liu Q, Tang R, Ma X. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis. Front Immunol 2021;12:732102. [PMID: 34512667 DOI: 10.3389/fimmu.2021.732102] [Reference Citation Analysis]
9 Amerikanou C, Papada E, Gioxari A, Smyrnioudis I, Kleftaki SA, Valsamidou E, Bruns V, Banerjee R, Trivella MG, Milic N, Medić-Stojanoska M, Gastaldelli A, Kannt A, Dedoussis GV, Kaliora AC; MAST4HEALTH. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacol Res 2021;171:105753. [PMID: 34224858 DOI: 10.1016/j.phrs.2021.105753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ma C, Yan K, Wang Z, Zhang Q, Gao L, Xu T, Sai J, Cheng F, Du Y. The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. Bioengineered 2021;12:2187-202. [PMID: 34096467 DOI: 10.1080/21655979.2021.1933302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gilgenkrantz H, Mallat A, Moreau R, Lotersztajn S. Targeting cell-intrinsic metabolism for antifibrotic therapy. J Hepatol 2021;74:1442-54. [PMID: 33631228 DOI: 10.1016/j.jhep.2021.02.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Wan Z, Lan R, Zhou Y, Xu Y, Wang Z, Luo Z, Miao J. Taurine-Mediated IDOL Contributes to Resolution of Streptococcus uberis Infection. Infect Immun 2021;89:e00788-20. [PMID: 33593888 DOI: 10.1128/IAI.00788-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Liu C, Schönke M, Zhou E, Li Z, Kooijman S, Boon MR, Larsson M, Wallenius K, Dekker N, Barlind L, Peng XR, Wang Y, Rensen PCN. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis. Cardiovasc Res 2021:cvab076. [PMID: 33693480 DOI: 10.1093/cvr/cvab076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
14 Cariello M, Piccinin E, Moschetta A. Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH. Cell Mol Gastroenterol Hepatol 2021;11:1519-39. [PMID: 33545430 DOI: 10.1016/j.jcmgh.2021.01.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
15 Abdul NS, Chuturgoon AA. Fumonisin B1 regulates LDL receptor and ABCA1 expression in an LXR dependent mechanism in liver (HepG2) cells. Toxicon 2021;190:58-64. [PMID: 33338448 DOI: 10.1016/j.toxicon.2020.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Wang L, Zhi Y, Ye Y, Zhang M, Ma X, Tie H, Ma X, Zheng N, Xia W, Song Y. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation. Biomed Res Int 2020;2020:8829346. [PMID: 33415161 DOI: 10.1155/2020/8829346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Buñay J, Fouache A, Trousson A, de Joussineau C, Bouchareb E, Zhu Z, Kocer A, Morel L, Baron S, Lobaccaro JA. Screening for liver X receptor modulators: Where are we and for what use? Br J Pharmacol 2021;178:3277-93. [PMID: 33080050 DOI: 10.1111/bph.15286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
18 Cao Q, Liu Z, Xiong Y, Zhong Z, Ye Q. Multiple Roles of 25-Hydroxycholesterol in Lipid Metabolism, Antivirus Process, Inflammatory Response, and Cell Survival. Oxid Med Cell Longev 2020;2020:8893305. [PMID: 33274010 DOI: 10.1155/2020/8893305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
19 Zhou M, Deng Y, Liu M, Liao L, Dai X, Guo C, Zhao X, He L, Peng C, Li Y. The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol 2021;890:173655. [PMID: 33068590 DOI: 10.1016/j.ejphar.2020.173655] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
20 Silwal P, Paik S, Jeon SM, Jo EK. Nuclear Receptors as Autophagy-Based Antimicrobial Therapeutics. Cells 2020;9:E1979. [PMID: 32867365 DOI: 10.3390/cells9091979] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Zhang J, Wieser A, Lin H, Li H, Hu M, Behrens IK, Schiergens TS, Gerbes AL, Steib CJ. Kupffer cell activation by different microbial lysates: Toll-like receptor-2 plays pivotal role on thromboxane A2 production in mice and humans. Eur J Immunol 2020;50:1988-97. [PMID: 32618365 DOI: 10.1002/eji.201948507] [Reference Citation Analysis]
22 Leussink S, Aranda-Pardos I, A-Gonzalez N. Lipid metabolism as a mechanism of immunomodulation in macrophages: the role of liver X receptors. Curr Opin Pharmacol 2020;53:18-26. [PMID: 32361182 DOI: 10.1016/j.coph.2020.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
23 Torres S, Abdullah Z, Brol MJ, Hellerbrand C, Fernandez M, Fiorotto R, Klein S, Königshofer P, Liedtke C, Lotersztajn S, Nevzorova YA, Schierwagen R, Reiberger T, Uschner FE, Tacke F, Weiskirchen R, Trebicka J. Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview. Int J Mol Sci 2020;21:E2027. [PMID: 32188134 DOI: 10.3390/ijms21062027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]